Investing in EDAP TMS S.A. (EDAP)

Valuation methodValue, $Upside, %
Artificial intelligence (AI)8.7315
Intrinsic value (DCF)4.58-39
Graham-Dodd Method1.54-80
Graham Formula0.00-100

Company description

EDAP TMS SA, with ticker symbol EDAP, is a global leader in therapeutic ultrasound technology that aims to improve patient care and treatment outcomes. The company was founded in 1979 and is headquartered in Lyon, France. They specialize in developing and manufacturing advanced ultrasound solutions for medical and research purposes, particularly in the field of urology and oncology. EDAP's flagship product, Ablatherm® HIFU (High-Intensity Focused Ultrasound), is the leading minimally invasive treatment for prostate cancer and is approved for use in over 50 countries. In addition to their innovative technology, EDAP also offers training and support for medical professionals to ensure the safe and effective use of their products. With a strong commitment to research and development, EDAP continues to expand its product portfolio and global presence, solidifying its position as a top player in the therapeutic ultrasound market. Their dedication to improving patient outcomes and advancing technology makes EDAP a company to watch in the healthcare industry.